Recently, several new tests of PSA derivatives such as PHI and 4K tests have improved the predictability of cancer detection, but there is still a concern about false positives and insignificant prostate cancer that does not require aggressive treatment [23,24,25]. This evidence concerns the gene KLK3 and Familial prostate cancer.